Dr. Gyorgy Baffy is an Associate Professor of Medicine at Harvard Medical School, Adjunct Associate Professor of Medicine in Gastroenterology at Boston University, and Chief of Gastroenterology at the VA Boston Healthcare System. He is a graduate of the University Medical School of Debrecen in Hungary. In addition, he obtained his PhD from his studies on growth factor-mediated calcium signaling as an NIH Fogarty Fellow in the Department of Biochemistry and Biophysics at the University of Pennsylvania. He trained in gastroenterology at the University of Michigan and the Brigham and Women’s Hospital. His research interests focus on various aspects of nonalcoholic fatty liver disease such as outcomes prediction, biomarkers of lipotoxicity, metabolic reprogramming, cancer bioenergetics, and hepatocellular carcinoma. He has been involved in various clinical trials that pertain to colorectal cancer screening. He organized multiple workshops and symposia on his research topics at major US conferences. He published over 60 peer-reviewed papers and book chapters. He has participated in numerous scientific review panels and provides editorial work for several journals in gastroenterology and hepatology. In 2014, he received a Fulbright US Scholar award to teach for a semester about current issues of obesity and related disorders at the University of Debrecen. He is a Fellow of the American College of Physicians, American Gastroenterological Association, and the American Association for the Study of Liver Diseases. He is the recipient of the Madaus Prize from the Madaus Liver Foundation and the Hetényi Medal of the Hungarian Gastroenterological Association.
- VA Boston Healthcare System
- University of Debrecen, MD
- Hungarian Academy of Sciences, PhD
- Published on 1/1/2020
Baffy G. Gut Microbiota and Cancer of the Host: Colliding Interests. Adv Exp Med Biol. 2020; 1219:93-107. PMID: 32130695.
- Published on 10/1/2019
Baffy G. Sarcopenic obesity in liver cancer: it is SO complicated. Hepatobiliary Surg Nutr. 2019 Oct; 8(5):560-562. PMID: 31673559.
- Published on 8/13/2019
Baffy G, Burns MM, Hoffmann B, Ramani S, Sabharwal S, Borus JF, Pories S, Quan SF, Ingelfinger JR. Scientific Authors in a Changing World of Scholarly Communication: What Does the Future Hold? Am J Med. 2020 01; 133(1):26-31. PMID: 31419421.
- Published on 2/1/2019
Baffy G. Digital Rectal Examination: Is It Warranted in the Endoscopy Suite? Am J Gastroenterol. 2019 02; 114(2):355. PMID: 30361620.
- Published on 11/9/2018
Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int. 2019 04; 39(4):598-609. PMID: 30312513.
- Published on 3/21/2018
Andolfi C, Baffy G, Fisichella PM. Whose patient is it? The path to multidisciplinary management of achalasia. J Surg Res. 2018 08; 228:8-13. PMID: 29907234.
- Published on 1/22/2018
Baffy G. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2018 Mar; 63(3):563-576. PMID: 29368124.
- Published on 11/13/2017
Sarkar M, Baffy G. Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality? Hepatology. 2018 01; 67(1):7-9. PMID: 28771759.
- Published on 2/21/2017
Baffy G, Fisichella PM. Gastrointestinal Surgery and Endoscopy: Recent Trends in Competition and Collaboration. Clin Gastroenterol Hepatol. 2017 06; 15(6):799-803. PMID: 28235574.
- Published on 1/11/2017
Baffy G. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities. Biochim Biophys Acta. 2017 08; 1858(8):655-664. PMID: 28088333.
View 50 more publications: View full profile at BUMC